Literature DB >> 10558970

Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal.

C O Tacket1, G Losonsky, S Livio, R Edelman, J Crabb, D Freedman.   

Abstract

Orally administered bovine immunoglobulins with specific activity against colonization factors of enterotoxigenic Escherichia coli (ETEC) could provide passive protection against ETEC challenge in volunteers. Twenty healthy adult volunteers ingested either a placebo or a partially enteric-coated preparation of bovine immunoglobulins with activity against the colonization factor antigens CFA/I, CS3, and CS6 and then were challenged with ETEC strain E24377A (CS1+, CS3+) administered with a standard meal. There was no difference in the incidence or severity of diarrhea among the 10 volunteers who received the bovine immunoglobulins and the 10 who received placebo. Either the specificity or titer of anti-colonization factor antibodies or the formulation of antibodies in this product was not adequate to provide passive protection against ETEC challenge.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558970     DOI: 10.1086/315157

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 2.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

3.  The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates.

Authors:  David A Rasko; M J Rosovitz; Garry S A Myers; Emmanuel F Mongodin; W Florian Fricke; Pawel Gajer; Jonathan Crabtree; Mohammed Sebaihia; Nicholas R Thomson; Roy Chaudhuri; Ian R Henderson; Vanessa Sperandio; Jacques Ravel
Journal:  J Bacteriol       Date:  2008-08-01       Impact factor: 3.490

4.  Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers.

Authors:  Wlodzimierz Otto; Boguslaw Najnigier; Teodor Stelmasiak; Roy M Robins-Browne
Journal:  Scand J Gastroenterol       Date:  2011-07       Impact factor: 2.423

Review 5.  Perspectives on immunoglobulins in colostrum and milk.

Authors:  Walter L Hurley; Peter K Theil
Journal:  Nutrients       Date:  2011-04-14       Impact factor: 5.717

6.  Impact of CD4+ T Cell Responses on Clinical Outcome following Oral Administration of Wild-Type Enterotoxigenic Escherichia coli in Humans.

Authors:  Monica A McArthur; Wilbur H Chen; Laurence Magder; Myron M Levine; Marcelo B Sztein
Journal:  PLoS Negl Trop Dis       Date:  2017-01-19

Review 7.  Effects of Bovine Immunoglobulins on Immune Function, Allergy, and Infection.

Authors:  Laurien H Ulfman; Jeanette H W Leusen; Huub F J Savelkoul; John O Warner; R J Joost van Neerven
Journal:  Front Nutr       Date:  2018-06-22

8.  Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.

Authors:  Jianmei Yu; Frederick Cassels; Tanya Scharton-Kersten; Scott A Hammond; Antoinette Hartman; Evelina Angov; Blaise Corthésy; Carl Alving; Gregory Glenn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.